{
    "clinical_study": {
        "@rank": "124424", 
        "arm_group": [
            {
                "arm_group_label": "Enteral nutrition", 
                "arm_group_type": "Experimental", 
                "description": "In the enteral nutrition group a nasojejunal feeding tube will be placed via esophagogastroduodenoscopy and the position confirmed radiographically. Nutritional support will be started within 24 hours of enrollment, supplying daily 105 kJ (25 kcal)/kg, and 1.5 g/kg of protein based on ideal body weight. An elemental product for enteral nutrition will be infused at a rate of 25 ml/h, and increased by 10 ml/h every 6 hours, until the target rate of 100 ml/h will be achieved within 24-48 hours."
            }, 
            {
                "arm_group_label": "Nil-by-mouth treatment", 
                "arm_group_type": "No Intervention", 
                "description": "The nil-by-mouth treatment consists intravenous fluid replacement according to assessed needs via peripheral veins. This will include crystalloid (0.9% saline and 5% glucose), and colloid (10% hydroxyethyl starch and 3.5% plasma expander - haemaccel) solutions."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this prospective randomised clinical trial is to compare beneficial and\n      harmful effects of the use enteral nutrition versus a nil-by-mouth and intravenous fluid\n      replacement principle of treatment in patients with moderate to severe acute pancreatitis\n      (AP).\n\n      The hypothesis:\n\n        -  enteral nutrition is no significantly better compared with the nil-by-mouth principle\n           regarding mortality, incidence of local and systemic complications, length of hospital\n           stay, and intensity of the inflammatory response in patients with moderate to severe AP\n\n        -  enteral nutrition has the same safety as nil-by-mouth principle in patients with\n           moderate to severe AP"
        }, 
        "brief_title": "Enteral Nutrition in Acute Pancreatitis", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": "Acute Pancreatitis", 
        "condition_browse": {
            "mesh_term": "Pancreatitis"
        }, 
        "detailed_description": {
            "textblock": "Patients with first attack of AP irrespective of etiology will be enrolled in the study, if\n      they are eligible according to the following criteria:\n\n      Inclusion criteria:\n\n        -  onset of symptoms consistent with AP within 72 hours before admission to the hospital\n\n        -  an 3-fold elevation of serum amylase or serum lipase over the upper limit of normal\n\n        -  APACHE II score 6 or more\n\n        -  a signed informed consent\n\n      Exclusion criteria:\n\n        -  patients < 18 years of age\n\n        -  pregnant and breastfeeding women"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  onset of symptoms consistent with AP within 72 hours before admission to the hospital\n\n          -  an 3-fold elevation of serum amylase or serum lipase over the upper limit of normal\n\n          -  APACHE II score 6 or more\n\n          -  a signed informed consent\n\n        Exclusion Criteria:\n\n          -  patients < 18 years of age\n\n          -  pregnant and breastfeeding women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "214", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01965873", 
            "org_study_id": "062-0000000-0211"
        }, 
        "intervention": {
            "arm_group_label": "Enteral nutrition", 
            "description": "Same as arm description", 
            "intervention_name": "Enteral nutrition", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pancreatitis, Acute necrotizing", 
            "Enteral nutrition", 
            "Fasting", 
            "Complications", 
            "Mortality"
        ], 
        "lastchanged_date": "October 17, 2013", 
        "number_of_arms": "2", 
        "official_title": "Enteral Nutrition for Treatment of Acute Pancreatitis - a Prospective, Randomized Clinical Trial", 
        "overall_official": {
            "affiliation": "Department of Gastroenterology, University Hospital Rijeka", 
            "last_name": "Davor \u0160timac, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Croatia: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "All-cause mortality", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01965873"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Rijeka", 
            "investigator_full_name": "Goran Poropat", 
            "investigator_title": "Medical doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Systemic complications (respiratory, renal, and/or cardiovascular failure)", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "measure": "Local complications (pancreatic necrosis, fluid collections, pseudocyst, abscess)", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "measure": "SIRS (Systemic inflammatory response syndrome)", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "measure": "Inflammatory response (CRP)", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "measure": "Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "4 weeks"
            }, 
            {
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "4 weeks"
            }
        ], 
        "source": "University Hospital Rijeka", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital Rijeka", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}